Evidence map›Paper›PMID 26067090›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2015

A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Silvia Morbelli, Valentina Garibotto, Elsmarieke Van De Giessen, Javier Arbizu, Gaël Chételat, Alexander Drezgza, Swen Hesse, Adriaan A Lammertsma, Ian Law, Sabina Pappata' and 3 more

Open access · greenAbstract readEditorialReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Comparison ofEJNMMI research · 2024
    Article
  7. Article
  8. Review
  9. Spatial normalization and quantification approaches of PET imaging for neurological disorders.European journal of nuclear medicine and molecular imaging · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Alzheimer's disease metabolic brain pattern in mild cognitive impairment.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  16. Article
  17. Validation ofNeuroinformatics · 2017
    Article
  18. The need of standardization and of large clinical studies in an emerging indication of [European journal of nuclear medicine and molecular imaging · 2017
    Article
  19. Review
  20. Dual-phase amyloid PET: hitting two birds with one stone.European journal of nuclear medicine and molecular imaging · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 7 countries.

Silvia MorbelliNuclear Medicine Unit, IRCCS San Martino - IST, Department of Health Sciences, University of Genoa, Largo R. Benzi 10, 16132, Genoa, Italy, silviadaniela.morbelli@hsanmartino.it.
Valentina Garibotto
Elsmarieke Van De Giessen
Javier Arbizu
Gaël Chételat
Alexander Drezgza
Swen Hesse
Adriaan A Lammertsma
Ian Law
Sabina Pappata'
Pierre Payoux
Marco Pagani
European Association of Nuclear Medicine
Amsterdam UMC Location University of Amsterdam · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLClinica Universidad de Navarra · ESCopenhagen University Hospital · DKInserm · FRInstitute of Biostructure and Bioimaging · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITKarolinska University Hospital · SELeipzig University · DEUniversité Toulouse III - Paul Sabatier · FRUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BrainCognitive DysfunctionDementiaEvidence-Based MedicineFemaleFluorodeoxyglucose F18ForecastingHumansMalePositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID26067090
OpenAlexW1882921643

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.